This is the authors' abstract. We don't add key points for this paper.
Jorge Casseb, Tatiane Assone, Augusto César Penalva de Oliveira; Use of dolutegravir to treat people living with HTLV-1-associated myelopathy (HAM), Clinic
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Casseb et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: